Renata Medical

Renata Medical is a private, commercial-stage medical device company addressing a critical gap in pediatric cardiology. The company has successfully developed and gained FDA approval for the Minima Stent System, a first-of-its-kind, re-expandable stent tailored for infants as small as 1.5 kg, designed to be dilated to adult sizes as the child grows. Founded in 2015 by executives with experience from Edwards Lifesciences, Renata is led by a team with deep expertise in cardiovascular devices and pediatric cardiology, including Chief Medical Officer Dr. Evan Zahn. The company is positioned in a high-need, niche market with limited competition, having transitioned from development to commercialization and early revenue generation.

A re-expandable stent platform specifically engineered for pediatric somatic growth. The Minima Stent System features an ultra-low profile delivery system for infant vessel access and a stent designed for serial catheter-based re-dilation to accommodate a patient's growth from infancy to adulthood.

Direct competition is currently minimal, as the Minima is the only FDA-approved stent specifically for infants. The primary competition comes from the off-label use of adult coronary or other stents, surgical interventions (patch repair), and balloon angioplasty alone—all of which are suboptimal solutions not designed for growth. Potential future competitors could include other startups or divisions of large medtech companies (e.g., Medtronic, Abbott, Boston Scientific) that develop pediatric-specific, re-expandable stent platforms.